PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING
PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING
复制标题
DOI:
10.1038/clpt.1980.181
复制
发表时间:
1980-01-01
影响因子:
6.7
通讯作者:
GILLESPIE, HK
中科院分区:
文献类型:
--
作者:
OHLSSON, A;LINDGREN, JE;GILLESPIE, HK
.delta.-9-Tetrahydrocannabinol (THC) was given i.v., by smoking and by mouth to 11 healthy subjects. Plasma profiles of THC after smoking and i.v. injection were similar, but plasma levels after oral doses were low and irregular, indicating slow and erratic absorption. Based on AUC[area under the concentration: time curve]0-360 min systemic availability of THC after smoking was estimated to be 18 .+-. 6%. Oral THC in a chocolate cookie provided systemic availability of 6 .+-. 3%. Of the 2 major clinical signs of cannabis intoxication, reddened conjunctivae persisted for as long as THC levels were > 5 ng/ml and tachycardia was a less reliable measurement of prevailing THC levels or high. The time courses of plasma concentrations and clinical high were of the same order for i.v. injection and smoking, with prompt onset and steady decline over 4 h. The appearance of high lagged behind the increase in plasma concentrations, suggesting that brain concentrations were increasing as plasma concentrations decreased. After oral THC, the onset of clinical effects was much slower and lasted longer, but effects occurred at much lower plasma concentrations than after the other 2 methods of administration.